NO20004045D0 - 2-(purin-9-yl)-tetrahydrofuran-3,4-diolderivater - Google Patents

2-(purin-9-yl)-tetrahydrofuran-3,4-diolderivater

Info

Publication number: NO20004045D0
Authority: NO; Norway
Prior art keywords: purin; tetrahydrofuran; diol derivative; diol; derivative
Prior art date: 1998-02-14

Application number

NO20004045A

Other languages

English (en)

Other versions

NO20004045L (no

Inventor

Chuen Chan

Caroline Mary Cook

Richard Peter Charles Cousins

Brian Cox

Frank Ellis

Stephen Swanson

David Edmund Bays

Hazel Joan Dyke

Joanna Victoria Geden

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-14

Filing date

2000-08-11

Publication date

2000-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26313119&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20004045(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-02-14 Priority claimed from GBGB9803169.3A external-priority patent/GB9803169D0/en

1998-06-23 Priority claimed from GBGB9813533.8A external-priority patent/GB9813533D0/en

2000-08-11 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2000-08-11 Publication of NO20004045D0 publication Critical patent/NO20004045D0/no

2000-08-11 Publication of NO20004045L publication Critical patent/NO20004045L/no

Links

YQUJSBYIKMQCIT-UHFFFAOYSA-N 2-purin-9-yloxolane-3,4-diol Chemical class OC1C(O)COC1N1C2=NC=NC=C2N=C1 YQUJSBYIKMQCIT-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO20004045A 1998-02-14 2000-08-11 2-(purin-9-yl)-tetrahydrofuran-3,4-diolderivater NO20004045L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9803169.3A GB9803169D0 (en)	1998-02-14	1998-02-14	Chemical compounds
GBGB9813533.8A GB9813533D0 (en)	1998-06-23	1998-06-23	Chemical compounds
PCT/EP1999/000915 WO1999041267A1 (en)	1998-02-14	1999-02-12	2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives

Publications (2)

Publication Number	Publication Date
NO20004045D0 true NO20004045D0 (no)	2000-08-11
NO20004045L NO20004045L (no)	2000-08-11

Family

ID=26313119

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20004045A NO20004045L (no)	1998-02-14	2000-08-11	2-(purin-9-yl)-tetrahydrofuran-3,4-diolderivater

Country Status (31)

Country	Link
US (1)	US6610665B1 (no)
EP (1)	EP1056759B1 (no)
JP (1)	JP2002503669A (no)
KR (1)	KR20010082512A (no)
AP (1)	AP2000001881A0 (no)
AR (1)	AR017457A1 (no)
AT (1)	ATE223429T1 (no)
AU (1)	AU757156B2 (no)
BR (1)	BR9907886A (no)
CA (1)	CA2319009A1 (no)
CO (1)	CO4990969A1 (no)
DE (1)	DE69902758T2 (no)
DK (1)	DK1056759T3 (no)
EA (1)	EA200000759A1 (no)
EE (1)	EE200000358A (no)
ES (1)	ES2183516T3 (no)
HR (1)	HRP20000538A2 (no)
HU (1)	HUP0100702A3 (no)
IL (1)	IL137402A0 (no)
IS (1)	IS5576A (no)
MA (1)	MA27121A1 (no)
NO (1)	NO20004045L (no)
NZ (1)	NZ505812A (no)
PE (1)	PE20000270A1 (no)
PL (1)	PL342396A1 (no)
PT (1)	PT1056759E (no)
SK (1)	SK12002000A3 (no)
SV (1)	SV1999000016A (no)
TR (1)	TR200002355T2 (no)
WO (1)	WO1999041267A1 (no)
YU (1)	YU50800A (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6514949B1 (en)	1994-07-11	2003-02-04	University Of Virginia Patent Foundation	Method compositions for treating the inflammatory response
YU44900A (sh)	1998-01-31	2003-01-31	Glaxo Group Limited	Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
AR017457A1 (es) *	1998-02-14	2001-09-05	Glaxo Group Ltd	Compuestos derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol, procesos para su preparacion, composiciones que los contienen y su uso en terapia para el tratamiento de enfermedades inflamatorias.
GB9813565D0 (en) *	1998-06-23	1998-08-19	Glaxo Group Ltd	Chemical compounds
GB9813554D0 (en)	1998-06-23	1998-08-19	Glaxo Group Ltd	Chemical compounds
EA200001224A1 (ru) *	1998-06-23	2001-08-27	Глаксо Груп Лимитед	Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
US7427606B2 (en)	1999-02-01	2008-09-23	University Of Virginia Patent Foundation	Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en)	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
US6232297B1 (en)	1999-02-01	2001-05-15	University Of Virginia Patent Foundation	Methods and compositions for treating inflammatory response
GB9930075D0 (en) *	1999-12-20	2000-02-09	Glaxo Group Ltd	Medicaments
US7638496B2 (en)	2000-02-15	2009-12-29	Valeant Pharmaceuticals North America	Nucleoside analogs with carboxamidine modified monocyclic base
GB0022695D0 (en)	2000-09-15	2000-11-01	Pfizer Ltd	Purine Derivatives
GB0115178D0 (en) *	2001-06-20	2001-08-15	Glaxo Group Ltd	Compounds
SG176313A1 (en)	2001-10-01	2011-12-29	Univ Virginia Patent Found	2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
US6930093B2 (en) *	2003-07-10	2005-08-16	Valeant Research & Development	Use of ribofuranose derivatives against inflammatory bowel diseases
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
TWI346109B (en)	2004-04-30	2011-08-01	Otsuka Pharma Co Ltd	4-amino-5-cyanopyrimidine derivatives
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
PE20060272A1 (es)	2004-05-24	2006-05-22	Glaxo Group Ltd	(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
WO2006023272A1 (en)	2004-08-02	2006-03-02	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having a2a agonist activity
US7576069B2 (en)	2004-08-02	2009-08-18	University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
CA2576826C (en)	2004-08-02	2014-09-30	University Of Virginia Patent Foundation	2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
US7910708B2 (en)	2005-10-21	2011-03-22	Novartis Ag	Anti-IL13 human antibodies
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
KR20090073121A (ko)	2006-09-29	2009-07-02	노파르티스 아게	Ｐｉ3ｋ 지질 키나제 억제제로서의 피라졸로피리미딘
KR20090075714A (ko)	2006-10-30	2009-07-08	노파르티스 아게	소염제로서의 헤테로시클릭 화합물
EP2231642B1 (en)	2008-01-11	2013-10-23	Novartis AG	Pyrimidines as kinase inhibitors
PL2391366T3 (pl)	2009-01-29	2013-04-30	Novartis Ag	Podstawione benzimidazole do leczenia gwiaździaków
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
EA201200260A1 (ru)	2009-08-12	2012-09-28	Новартис Аг	Гетероциклические гидразоны и их применение для лечения рака и воспаления
MY162604A (en)	2009-08-17	2017-06-30	Intellikine Llc	Heterocyclic compounds and uses thereof
MX2012002179A (es)	2009-08-20	2012-03-16	Novartis Ag	Compuestos heterociclicos de oxima.
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
JP2014505088A (ja)	2011-02-10	2014-02-27	ノバルティスアーゲー	Ｃ−ＭＥＴチロシンキナーゼ阻害剤としての［１，２，４］トリアゾロ［４，３−ｂ］ピリダジン化合物
EP2678016B1 (en)	2011-02-23	2016-08-10	Intellikine, LLC	Heterocyclic compounds and uses thereof
AU2012220572A1 (en)	2011-02-25	2013-08-29	Irm Llc	Compounds and compositions as trk inhibitors
UY34329A (es)	2011-09-15	2013-04-30	Novartis Ag	Compuestos de triazolopiridina
US20130209543A1 (en)	2011-11-23	2013-08-15	Intellikine Llc	Enhanced treatment regimens using mtor inhibitors
CN110507654A (zh)	2012-04-03	2019-11-29	诺华有限公司	有酪氨酸激酶抑制剂的组合产品和其应用
EP2968340A4 (en)	2013-03-15	2016-08-10	Intellikine Llc	COMBINING KINASE INHIBITORS AND USES THEREOF
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
KR20170036037A (ko)	2014-07-31	2017-03-31	노파르티스 아게	조합 요법
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9414193D0 (en) *	1994-07-14	1994-08-31	Glaxo Group Ltd	Compounds
TW528755B (en)	1996-12-24	2003-04-21	Glaxo Group Ltd	2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
AR017457A1 (es) *	1998-02-14	2001-09-05	Glaxo Group Ltd	Compuestos derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol, procesos para su preparacion, composiciones que los contienen y su uso en terapia para el tratamiento de enfermedades inflamatorias.
EA200001224A1 (ru) *	1998-06-23	2001-08-27	Глаксо Груп Лимитед	Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола

1999
- 1999-02-11 AR ARP990100570A patent/AR017457A1/es active IP Right Grant
- 1999-02-11 PE PE1999000123A patent/PE20000270A1/es not_active Application Discontinuation
- 1999-02-11 CO CO99008188A patent/CO4990969A1/es unknown
- 1999-02-12 US US09/622,313 patent/US6610665B1/en not_active Expired - Fee Related
- 1999-02-12 EE EEP200000358A patent/EE200000358A/xx unknown
- 1999-02-12 ES ES99906229T patent/ES2183516T3/es not_active Expired - Lifetime
- 1999-02-12 DE DE69902758T patent/DE69902758T2/de not_active Expired - Fee Related
- 1999-02-12 NZ NZ505812A patent/NZ505812A/en unknown
- 1999-02-12 IL IL13740299A patent/IL137402A0/xx unknown
- 1999-02-12 TR TR2000/02355T patent/TR200002355T2/xx unknown
- 1999-02-12 SK SK1200-2000A patent/SK12002000A3/sk unknown
- 1999-02-12 HR HR20000538A patent/HRP20000538A2/hr not_active Application Discontinuation
- 1999-02-12 KR KR1020007008866A patent/KR20010082512A/ko not_active Withdrawn
- 1999-02-12 AP APAP/P/2000/001881A patent/AP2000001881A0/en unknown
- 1999-02-12 HU HU0100702A patent/HUP0100702A3/hu unknown
- 1999-02-12 JP JP2000531459A patent/JP2002503669A/ja active Pending
- 1999-02-12 EP EP99906229A patent/EP1056759B1/en not_active Expired - Lifetime
- 1999-02-12 DK DK99906229T patent/DK1056759T3/da active
- 1999-02-12 BR BR9907886-4A patent/BR9907886A/pt not_active IP Right Cessation
- 1999-02-12 AT AT99906229T patent/ATE223429T1/de not_active IP Right Cessation
- 1999-02-12 WO PCT/EP1999/000915 patent/WO1999041267A1/en not_active Ceased
- 1999-02-12 PL PL99342396A patent/PL342396A1/xx unknown
- 1999-02-12 SV SV1999000016A patent/SV1999000016A/es not_active Application Discontinuation
- 1999-02-12 EA EA200000759A patent/EA200000759A1/ru unknown
- 1999-02-12 PT PT99906229T patent/PT1056759E/pt unknown
- 1999-02-12 CA CA002319009A patent/CA2319009A1/en not_active Abandoned
- 1999-02-12 AU AU26235/99A patent/AU757156B2/en not_active Ceased
- 1999-02-12 YU YU50800A patent/YU50800A/sh unknown
- 1999-02-12 MA MA25462A patent/MA27121A1/fr unknown
2000
- 2000-07-25 IS IS5576A patent/IS5576A/is unknown
- 2000-08-11 NO NO20004045A patent/NO20004045L/no unknown

Also Published As

Publication number	Publication date
HRP20000538A2 (en)	2000-12-31
SV1999000016A (es)	1999-10-27
DE69902758D1 (de)	2002-10-10
AR017457A1 (es)	2001-09-05
AU2623599A (en)	1999-08-30
HK1032062A1 (en)	2001-07-06
EA200000759A1 (ru)	2001-04-23
JP2002503669A (ja)	2002-02-05
ES2183516T3 (es)	2003-03-16
PE20000270A1 (es)	2000-05-20
MA27121A1 (fr)	2005-01-03
SK12002000A3 (sk)	2001-07-10
KR20010082512A (ko)	2001-08-30
HUP0100702A2 (hu)	2002-01-28
PL342396A1 (en)	2001-06-04
DK1056759T3 (da)	2003-01-06
TR200002355T2 (tr)	2000-11-21
AU757156B2 (en)	2003-02-06
CO4990969A1 (es)	2000-12-26
CA2319009A1 (en)	1999-08-19
AP2000001881A0 (en)	2000-09-30
IS5576A (is)	2000-07-25
WO1999041267A1 (en)	1999-08-19
DE69902758T2 (de)	2003-05-15
HUP0100702A3 (en)	2003-01-28
ATE223429T1 (de)	2002-09-15
NO20004045L (no)	2000-08-11
US6610665B1 (en)	2003-08-26
IL137402A0 (en)	2001-07-24
PT1056759E (pt)	2003-01-31
YU50800A (sh)	2003-04-30
EP1056759A1 (en)	2000-12-06
EE200000358A (et)	2001-10-15
EP1056759B1 (en)	2002-09-04
BR9907886A (pt)	2000-10-17
NZ505812A (en)	2002-03-01

Publication	Publication Date	Title
ATE226957T1 (de)	2002-11-15	2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivat
NO20006548L (no)	2001-02-22	2-(purin-9-yl)-tetrahydrofuran-3,4-diolderivater
ATE223429T1 (de)	2002-09-15	2-(purin-9-yl)-tetrahydrofuran-3,4-diol- derivative
NO20006521D0 (no)	2000-12-20	2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivater
NO993114D0 (no)	1999-06-23	2-(purin-9-yl)-tetrahydrofuran-3,4-diolderivater
SI1056759T1 (en)	2003-04-30	2-(purin-9-yl) -tetrahydrofuran-3, 4-diol derivatives
ZA99689B (en)	2000-07-28	2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives.
ZA991154B (en)	2000-08-14	2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives.
HK1033761A (en)	2001-09-21	2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
HK1033760A (en)	2001-09-21	2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
ZA9711535B (en)	1999-06-22	2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives